JOHNSON & JOHNSONJNJ

Market cap
$509.6B
P/E ratio
2011/012012/012012/122013/122014/122016/012017/012017/122018/122019/122021/012022/012023/012023/122024/12
Depreciation & amortization2,9393,1583,6664,1043,8953,7463,7545,6426,9297,0097,2317,3906,9707,4867,339
Stock-based compensation6146216627287928748789629789771,0051,1351,1381,1621,176
Cash from operations 16,38514,29815,39617,41418,47119,27918,76721,05622,20123,41623,53623,41021,19422,79124,266
Capital expenditures-2,384-2,893-2,934-3,595-3,714-3,463-3,226-3,279-3,670-3,498-3,347-3,652-4,009-4,543-4,424
Cash from investing -7,854-4,612-4,510-5,103-12,305-7,735-4,761-14,868-3,167-6,194-20,825-8,683-12,371878-18,599
Repurchases of common stock2,7972,52512,9193,5387,1245,2908,9796,3585,8686,7463,2213,4566,0355,0542,432
Proceeds from issuance of term debt, net1,1184,470453,6072,0987512,0048,992537,43152-6,660
Repayments of term debt32168041,5931,844682,2231,7771,5552,8231,0641,8022,1341,5511,453
Cash from financing -4,980-4,452-20,562-6,091-12,260-10,846-8,551-7,673-18,510-18,015-6,120-14,047-8,871-15,825-3,132
Free cash flow
FCF margin (%)-